Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
Completed
Bayer
Phase 3
The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus
vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer
that has spread to other organs and whose disease has worsened after treatment with
irinotecan.
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
Completed
Novartis Pharmaceuticals
Phase 3
The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus
vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer
that has spread to other organs and whose disease has worsened after treatment with
irinotecan.
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Completed
Bayer
Phase 3
To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus
oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread
to other organs and are seeking first chemotherapy treatment
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Completed
Novartis
Phase 3
To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus
oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread
to other organs and are seeking first chemotherapy treatment
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.